Panacea Pharmaceuticals, Inc.

207 Perry Parkway, Suite 2
Gaithersburg, MD 20877
http://www.panaceapharma.com
24 Employees

SBIR Award Summary

Total Number of Awards 8
Total Value of Awards $1.53MM
First Award Date 08/01/01
Most Recent Award Date 08/10/09

Key Personnel

Last Name Name Awards Contact
Biswas Biswajit Biswas 1
Keith Stephen Keith 1 Message
Lebowitz Michael Lebowitz 1
Ghanbari Hossein A Ghanbari 3
Jiang Zhi-Gang Jiang 3

8 Awards Won

Phase 1 STTR

Institution: Hygea Inst. of Preventive Medicine

Agency: Army
Topic: A09A-T026
Budget: 08/10/09 - 03/09/10

Panacea Pharmaceuticals proposes to develop an antibiotic product consisting of lytic bacteriophage that kills Acinetobacter baumannii for eventual use in human wound infections. The Phase 1 project will identify candidate bacteriophages from raw sewage and soil by mixing sewage/soil concentrates with A. baumannii, growing the bacteria on agar ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/07 - 04/30/08

DESCRIPTION (provided by applicant): Ischemia/hypoxia is a significant contributor to neurodegeneration. A typical case is ischemic stroke. Currently, more than 4 million people in the U.S are living with the consequences of stroke. Stroke has become the third leading cause of death in this country, a major cause of long-term disability, and a ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/06 - 04/30/07

DESCRIPTION (provided by applicant): Ischemia/hypoxia is a significant contributor to neurodegeneration. A typical case is ischemic stroke. Currently, more than 4 million people in the U.S are living with the consequences of stroke. Stroke has become the third leading cause of death in this country, a major cause of long-term disability, and a ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/04 - 09/30/05

DESCRIPTION (provided by applicant): Alzheimer disease (AD) is the most common form of dementia and primarily affects older individuals. Currently approximately 4 million people in the United States (US) are affected with AD, and that number is expected to grow as the US population ages. Almost half of the population over age 85 have Alzheimer's...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/15/04 - 02/28/05

DESCRIPTION (provided by applicant): Ischemia/hypoxia is a significant contributor to neurodegeneration. Both focal/localized and/or global ischemia can induce considerable neuronal injury. A typical case of focal ischemia is ischemic stroke in which the transport of oxygen and glucose to localized regions of the brain is halted by blockage of a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/27/02 - 08/31/03

DESCRIPTION (provided by applicant): Current methods for the diagnosis and management of neoplastic disease rely heavily on imaging techniques, such as X-ray, CT scanning and MRI, tissue biopsy and histopathological findings. Much effort has been put forth to identify other less costly and less invasive means for the diagnosis and monitoring of...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/02 - 11/30/02

Increased expression of human aspartyl (asparaginyl) beta-hydroxylase (HAAH) has been observed in multiple tumor types. HAAH in tumor cells is localized to the cell surface. Its over-expression is sufficient to induce cellular transformation, increase motility and invasiveness, and establish tumor formation. As such, HAAH represents an important...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/01 - 04/30/02

DESCRIPTION (provided by applicant): Parkinson's disease (PD) affects 1 percent of the population over 60 years of age and is one of the most common motor disorders. A pathologic hallmark of PD is the deposition of intracellular protein inclusions known as Lewy bodies in the neurons of affected individuals. The pro...